HCID 14198890, compound → HCID 58530408, compound
Reaction equation
[F:1][C:2]([F:26])([F:25])[C:3]1[CH:20]=[C:19]([C:21]([F:24])([F:23])[F:22])[CH:18]=[CH:17][C:4]=1[CH2:5][N:6]1[C:14]2[C:9](=[CH:10][C:11]([CH:15]=O)=[CH:12][CH:13]=2)[CH:8]=[N:7]1.O1CCCCC1[O:33][N:34]1[C:38](=[O:39])[CH2:37][S:36][C:35]1=[O:40]>>[F:26][C:2]([F:1])([F:25])[C:3]1[CH:20]=[C:19]([C:21]([F:22])([F:23])[F:24])[CH:18]=[CH:17][C:4]=1[CH2:5][N:6]1[C:14]2[C:9](=[CH:10][C:11](/[CH:15]=[C:37]3/[C:38](=[O:39])[N:34]([OH:33])[C:35](=[O:40])[S:36]/3)=[CH:12][CH:13]=2)[CH:8]=[N:7]1Participants
3
Procedure
(5Z)-5-({1-[2,4-Bis(trifluoromethyl)benzyl]-1H-indazol-5-yl}methylidene)-3-hydroxy-1,3-thiazolidine-2,4-dione was prepared from [2,4-bis(trifluoromethyl)benzyl]-1H-indazol-5-carbaldehyde (from Example 6) and 3-(tetrahydropyran-2-yl)oxy-1,3-thiazolidine-2,4-dione (from Example 288) following General Procedure F.
Sources & evidence
- ORD record
- ord-d8a53918753f49f5a6f7b08f0539a88f
- Source dataset
- uspto-grants-2014_08
- Patent number
- US08796256B2
Reaction notes
Loading…